UK - South East Growth Fund reaps 5x return on BioAnaLab exit
Regional venture investor South East Growth Fund (SEGF) has wholly exited its investment in biotechnology company BioAnaLab through a trade sale to Millipore Corporation, generating a return of 5x money and an IRR of 28%.
Oxford-based BioAnaLab was spun out of Oxford University in 2002. The company provides a broad range of services to assist with evaluating biologic drugs and advancing them through the drug development pipeline to market. Services offered include assay transfer/development, validation and sample analysis, pharmacokinetics/toxicokinetics, immunogenicity, biological potency and vaccine services.
Millimore Corporation provides technologies, tools and services to the global life science industry.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








